(Q43491985)

24 November 2017

title

Molecular subtypes of glioma identified by genome-wide methylation profiling (English)

1 reference

24 November 2017

Nanne K Kloosterhof

1

1 reference

24 November 2017

Johan J de Rooi

2

1 reference

24 November 2017

Max Kros

3

1 reference

24 November 2017

Paul H C Eilers

4

1 reference

24 November 2017

Peter A E Sillevis Smitt

5

1 reference

24 November 2017

Martin J van den Bent

6

1 reference

24 November 2017

Pim J French

7

1 reference

24 November 2017

publication date

30 April 2013

1 reference

Genes, Chromosomes and Cancer

24 November 2017

published in

1 reference

24 November 2017

volume

52

1 reference

24 November 2017

issue

7

1 reference

24 November 2017

page(s)

665-674

1 reference

IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo

24 November 2017

cites work

1 reference

Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.

21 January 2018

1 reference

DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma

21 January 2018

1 reference

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis

21 January 2018

1 reference

Intrinsic molecular subtypes of glioma are prognostic and predict benefit from adjuvant procarbazine, lomustine, and vincristine chemotherapy in combination with other prognostic factors in anaplastic oligodendroglial brain tumors: a report from EOR

21 January 2018

1 reference

21 January 2018

Epigenetics in cancer

1 reference

DNA methylation in glioblastoma: impact on gene expression and clinical outcome

21 January 2018

1 reference

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

Gene expression profiles associated with treatment response in oligodendrogliomas.

21 January 2018

1 reference

Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.

21 January 2018

1 reference

Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma

21 January 2018

1 reference

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

21 January 2018

1 reference

Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA

21 January 2018

1 reference

Molecular subclassification of diffuse gliomas: seeing order in the chaos

21 January 2018

1 reference

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine

21 January 2018

1 reference

Are clusters found in one dataset present in another dataset?

21 January 2018

1 reference

Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?

21 January 2018

1 reference

Mutation and cancer: statistical study of retinoblastoma

21 January 2018

1 reference

Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome

21 January 2018

1 reference

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis

21 January 2018

1 reference

Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes

21 January 2018

1 reference

A microarray-based DNA methylation study of glioblastoma multiforme

21 January 2018

1 reference

Neuropathological diagnostic accuracy.

21 January 2018

1 reference

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome

21 January 2018

1 reference

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02.

21 January 2018

1 reference

CpG island methylator phenotype in colorectal cancer

21 January 2018

1 reference

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

21 January 2018

1 reference

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

21 January 2018

1 reference

A hypermethylated phenotype is a better predictor of survival than MGMT methylation in anaplastic oligodendroglial brain tumors: a report from EORTC study 26951.

21 January 2018

1 reference

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production

21 January 2018

1 reference

CpG island hypermethylation in human astrocytomas

21 January 2018

1 reference

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

21 January 2018

1 reference

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/GCC.22062

1 reference

24 November 2017

1 reference